Beta cell therapy - Beta-CellAlternative Names: BetaGraft; BetaGraft1.0
Latest Information Update: 27 Jul 2016
At a glance
- Originator Beta-Cell
- Class Cell therapies
- Mechanism of Action Pancreatic beta cell replacements
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Diabetes mellitus
Most Recent Events
- 27 Jul 2016 Preclinical trials in Diabetes mellitus in Belgium (Parenteral)